Autentificare
NeuroPsy InfoHubÎnțelege · Sprijin · ProgresCere sprijin
← Toate temele

Autism + ADHD

La intersecția autism–ADHD.

109 articole
← Toate secțiunile

Studii și știri

PublicToțiPentru oricineSpecialiști
VârstăToate vârsteleCopiiTineriAdulțiVârstnici
StudiuAutism + ADHDÎncredere bună01.07.2026

Substance Use Disorder and Generalized Anxiety Disorder in University Students: A Cross-Sectional Study from Cameroon

This cross-sectional study of 917 university students in Cameroon found that 15.7% met criteria for substance use disorder and 26.4% for generalized anxiety disorder, with students having substance use disorder being nearly three times more likely to experience anxiety symptoms. Male gender, prior psychiatric history, and living alone were identified as additional risk factors for co-occurrence of both conditions.

StudiuAutism + ADHDÎncredere bună01.07.2026

Anxiety Symptom Networks in Major Depressive Disorder and Bipolar Disorder: A Comparative Network Analysis

This cross-sectional study of 815 patients compared anxiety symptom networks between major depressive disorder (MDD) and bipolar disorder (BD) using the Beck Anxiety Inventory and network analysis techniques. While both conditions showed similar core anxiety symptoms (loss of control, choking sensations, breathing difficulties, unsteadiness, shakiness), MDD demonstrated stronger overall network connectivity than BD, suggesting different patterns of symptom interconnection despite comparable symptom profiles.

StudiuAutism + ADHDÎncredere bună01.07.2026

Cord Blood Acylcarnitine Profile and Risk of ADHD and Autism in Childhood: A Prospective Birth Cohort Study

This prospective study examined whether acylcarnitine levels in cord blood—metabolites reflecting mitochondrial fatty acid metabolism—predict childhood ADHD and autism risk in 995 children. Higher short-chain and long-chain acylcarnitines were associated with significantly increased odds of ADHD and autism, suggesting early metabolic biomarkers may identify neurodevelopmental risk.

StudiuAutism + ADHDÎncredere înaltă30.06.2026

Dietary Patterns and Risk of Depression Symptoms and Anxiety Disorder: A Prospective Cohort Study

This longitudinal study of over 6,900 adults examined associations between empirically-derived dietary patterns and subsequent risk of depression and anxiety using annual validated screening questionnaires. High consumption of fast food and sugar was associated with approximately doubled risk of both depression symptoms and anxiety disorder, while vegetable-rich and vegetarian-like diets showed no protective effect in the total population.

StudiuAutism + ADHDÎncredere bună30.06.2026

HPT Axis Dysregulation in Mood and Anxiety Disorders: Clinical Utility of Thyroid Hormone Assessment in Psychiatric Inpatients

This comparative study examined thyroid function (TSH, FT4, FT3) in 88 hospitalized patients with major depressive disorder, generalized anxiety disorder, or bipolar disorder, finding significantly elevated TSH and higher subclinical hypothyroidism prevalence in depression patients. The research explores correlations between thyroid parameters and symptom severity using validated psychiatric rating scales while controlling for non-thyroidal illness effects.

StudiuAutism + ADHDÎncredere înaltă30.06.2026

Prevalence and Trends of Developmental Disabilities Among US Children and Adolescents Aged 3 to 17 Years From 2016 to 2024

This epidemiological study analyzed national survey data from 2016–2024 to examine prevalence trends in ADHD, autism spectrum disorder, learning disabilities, intellectual disability, and other developmental delays in US children aged 3–17 years. Results showed significant increases in ADHD, learning disabilities, and autism prevalence, with distinct age patterns, while intellectual disability remained stable, highlighting a growing public health challenge requiring enhanced early identification and research.

StudiuAutism + ADHDÎncredere înaltă27.06.2026

Validation of the German Parent-Report Anxiety Scale for Autistic Children: Addressing Diagnostic Overlap and Autism-Specific Anxiety Patterns

This validation study examined the German version of the Anxiety Scale for Children with Autism Spectrum Disorder-Parent Version (ASC-ASD-P) in 317 youth at an autism clinic, including 120 autistic children, demonstrating excellent internal consistency and convergent validity with established behavioral measures. Autistic youth showed higher anxiety and uncertainty scores than non-autistic peers, confirming the scale's sensitivity to autism-specific anxiety presentations, though some subscales require refinement for broader applicability across the autism spectrum.

StudiuAutism + ADHDÎncredere înaltă26.06.2026

Agomelatine versus escitalopram for depression in people with epilepsy: A randomized controlled trial

This double-blind randomized trial compared agomelatine and escitalopram in 51 people with epilepsy and major depressive disorder, evaluating effects on depression, seizure frequency, sleep, cognition, and quality of life. Both medications improved depression similarly with minimal adverse events; escitalopram showed greater quality-of-life improvement while agomelatine showed better verbal memory outcomes, with no significant effects on seizure frequency in either group.

StudiuAutism + ADHDÎncredere bună26.06.2026

Symptomatic hyperprolactinemia mimicking pituitary pathology in a child with Landau-Kleffner syndrome and autism spectrum disorder: case report

A 12-year-old girl with autism spectrum disorder, Landau-Kleffner syndrome, and intellectual disability developed galactorrhea, vision problems, and falls while taking risperidone, with laboratory findings showing elevated prolactin (40.2 ng/mL) but normal imaging excluding pituitary tumor. Switching from risperidone to olanzapine resulted in complete symptom resolution and prolactin normalization (2.2 ng/mL) within three months, highlighting the importance of monitoring prolactin levels in children on antipsychotic medication.

StudiuAutism + ADHDÎncredere bună24.06.2026

Effect of Prior Depression Diagnosis on Bipolar Disorder Outcomes: A Retrospective Cohort Study

This retrospective cohort study analyzed 5,595 Japanese patients newly diagnosed with bipolar disorder to examine whether a prior depression diagnosis and its duration affected psychiatric and all-cause hospitalization rates and mortality. Patients with prior depression history showed slightly lower all-cause hospitalization risk (HR=0.87), with duration of preceding depression (≥1 year vs <1 year) not significantly altering psychiatric hospitalization outcomes.

StudiuAutism + ADHDÎncredere bună23.06.2026

Autism in Schizophrenia and Its Original Link to Self-Disorder: Returning a Borrowed Concept

This academic paper traces the historical origins of the term 'autism' coined by Eugen Bleuler in 1910 to describe schizophrenia, and how the concept was later borrowed to describe autism spectrum disorder, leading to diagnostic confusion. The authors argue that autistic features in schizophrenia differ fundamentally from autism spectrum disorder—rooted in self-disorder rather than developmental autism—and propose this distinction is crucial for accurate differential diagnosis and appropriate treatment.

StudiuAutism + ADHDÎncredere bună22.06.2026

Association Between Bipolar Disorder and Parkinson's Disease: A Review of Dopaminergic Mechanisms and Clinical Implications

This literature review examines the association between bipolar disorder and Parkinson's disease, focusing on their shared dopaminergic dysfunction in nigrostriatal and mesolimbic pathways. Recent analyses and meta-analyses show increased risk of developing Parkinson's disease in bipolar disorder patients, though differentiating idiopathic from medication-induced parkinsonism requires careful evaluation including DAT scans.

StudiuAutism + ADHDÎncredere înaltă22.06.2026

Structural and Metabolic Correlates of Neuropsychological Profiles in Multiple System Atrophy and Parkinson's Disease

This comparative neuroimaging study examined cognitive impairment in 11 patients with multiple system atrophy with parkinsonism (MSA-P) and 11 with Parkinson's disease using neuropsychological testing, diffusion tensor imaging, and PET imaging. Findings showed MSA-P patients had greater executive dysfunction and higher depression/anxiety scores, with specific correlations between cognitive performance and frontostriatal white matter integrity and glucose metabolism in both conditions.

StudiuAutism + ADHDÎncredere înaltă22.06.2026

Formal and Informal Care Costs Following Traumatic Brain Injury and Spinal Cord Injury from Motor Vehicle Accidents: A Cross-Sectional Australian Study

This study compared the weekly utilization and associated costs of formal and informal care in 81 people with traumatic brain injury and 30 with spinal cord injury from motor vehicle accidents in Australia. Spinal cord injury (tetraplegia/paraplegia) required significantly higher costs for both formal and informal care, while informal care costs exceeded formal care costs for both conditions, highlighting the critical yet underacknowledged role of family caregiving in supporting recovery.

StudiuAutism + ADHDÎncredere bună22.06.2026

Attention and Behavioral Problems as Mediators of Internet Gaming Disorder in Youth With Family Addiction History

This study of 2,586 adolescents (ages 11-19) examined how attention problems and externalizing behaviors mediate the relationship between parental addiction history and internet gaming disorder. Higher attention and externalizing problems were significantly associated with IGD, with mediation analysis confirming these symptoms partially explain how family addiction history increases gaming disorder risk in youth.

StudiuAutism + ADHDÎncredere bună22.06.2026

Problematic Social Networking Site Use: Effects on Mental Health and Brain Function

Excessive social networking site use is associated with elevated rates of depression, anxiety, OCD, ADHD, and sleep disturbances, with preliminary neuroimaging evidence suggesting reduced gray matter in regions related to reward processing and inhibitory control. Cognitive Behavior Therapy shows promise as a short-term intervention, though more research is needed to fully understand the neurobiological mechanisms and treatment efficacy.